Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px
Person › Details

Rolad Eils (DKFZ (German Cancer Research Center, GCRC))

Eils, Roland (Helmholtz 201006 Professor DKFZ Heidelberg)

 

Organisation Organisation DKFZ (German Cancer Research Center, GCRC)
  Group Helmholtz-Gemeinschaft (HGF) (Group)
Product Product oncology
     

Life Technologies Corporation. (6/2/10). "Press Release: Life Technologies Partners with German Cancer Research Center to Create World-class Genome Sequencing Facility". Carlsbad, CA & Heidelberg.

LifeTechnologies Corporation (NASDAQ: LIFE) and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.

The center will operate 10 SOLiD(TM) 4 hq systems acquired by DKFZ and will initially sequence 1000 whole human cancer genomes for Germany's national contribution to the International Cancer Genome Consortium (ICGC). The facility will be partially funded by the German Federal Ministry of Education and Research.

Systems biology is the study of an organism as an integrated and interacting network of genes, proteins and biochemical reactions that give rise to life. Often, experiments in systems biology require precise measurements of cellular events over time and assess changes in DNA sequence, RNA transcription or genomic copy number. Therefore, these experiments require substantially more sequencing throughput than experiments that are not examining such dynamic changes in cellular events.

"Our aim is to understand the dynamic complexity of cellular processes on both the DNA and RNA level and how slight perturbations of those pathways contribute to the development of diseases like cancer," said Professor Roland Eils from DKFZ. "Therefore, it is of the utmost importance to be able to obtain quantitative precise measurements. We are confident that this collaboration with Life Technologies will help us generate the highest quality data possible using the SOLiD(TM) technology."

The SOLiD(TM) System is used globally in experiments to better understand the genetic nature of diseases such as cancer, diabetes, neurological disorders and other diseases. Its throughput, accuracy and flexibility allow researchers to generate the data they need for their experiments.

"Life Technologies is proud to be the technology partner of choice for this new and exciting sequencing center and to be working with DKFZ, a renowned institution in Germany in life science research devoted to studying the complexities of human diseases like cancer," said Mark Stevenson, President and Chief Operating Officer for Life Technologies. "This center will be the first facility that will systematically bring high-throughput sequencing technologically into systems biology applications on a large scale."

About Life Technologies (http://www.lifetechnologies.com)

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

Life Technologies
Patty Zamora,
760-476-7818
patty.zamora@lifetech.com

   
Record changed: 2017-04-09

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px


More documents for Rolad Eils


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top